======= RPS4X ======= == Gene Information == * **Official Symbol**: RPS4X * **Official Name**: ribosomal protein S4 X-linked * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6191|6191]] * **UniProt**: [[https://www.uniprot.org/uniprot/P62701|P62701]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RPS4X&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RPS4X|Open PubMed]] * **OMIM**: [[https://omim.org/entry/312760|Open OMIM]] == Function Summary == * **Entrez Summary**: Cytoplasmic ribosomes, organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes ribosomal protein S4, a component of the 40S subunit. Ribosomal protein S4 is the only ribosomal protein known to be encoded by more than one gene, namely this gene and ribosomal protein S4, Y-linked (RPS4Y). The 2 isoforms encoded by these genes are not identical, but are functionally equivalent. Ribosomal protein S4 belongs to the S4E family of ribosomal proteins. This gene is not subject to X-inactivation. It has been suggested that haploinsufficiency of the ribosomal protein S4 genes plays a role in Turner syndrome; however, this hypothesis is controversial. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |RS4NT| |Ribosomal S4e| |small ribosomal subunit| |rRNA binding| |polysome| |ribosome| |cytosolic small ribosomal subunit| |cytoplasmic ribonucleoprotein granule| |SRP-dependent cotranslational protein targeting to membrane| |cotranslational protein targeting to membrane| |protein targeting to ER| |establishment of protein localization to endoplasmic reticulum| |viral transcription| |nuclear-transcribed mRNA catabolic process, nonsense-mediated decay| |positive regulation of translation| |response to ethanol| |viral gene expression| |protein localization to endoplasmic reticulum| |translational initiation| |positive regulation of cellular amide metabolic process| |ribonucleoprotein complex| |protein targeting to membrane| |structural constituent of ribosome| |nuclear-transcribed mRNA catabolic process| |mRNA catabolic process| |response to alcohol| |RNA catabolic process| |establishment of protein localization to membrane| |synapse| |response to antibiotic| |regulation of translation| |protein targeting| |nucleobase-containing compound catabolic process| |translation| |regulation of cellular amide metabolic process| |peptide biosynthetic process| |focal adhesion| |establishment of protein localization to organelle| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |protein localization to membrane| |organic cyclic compound catabolic process| |response to toxic substance| |posttranscriptional regulation of gene expression| |amide biosynthetic process| |peptide metabolic process| |mRNA metabolic process| |viral process| |protein localization to organelle| |symbiotic process| |cellular amide metabolic process| |interspecies interaction between organisms| |cellular macromolecule catabolic process| |positive regulation of cell population proliferation| |intracellular protein transport| |response to drug| |macromolecule catabolic process| |RNA binding| |organonitrogen compound biosynthetic process| |protein transport| |intracellular transport| |peptide transport| |response to oxygen-containing compound| |amide transport| |cellular protein localization| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |positive regulation of protein metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |macromolecule biosynthetic process| |organic substance catabolic process| |cellular catabolic process| |establishment of localization in cell| |nitrogen compound transport| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|-2.71| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.12| |[[:results:exp33|Rotenone 2μM R00 exp33]]|-1.77| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-1.72| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|1.7| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|1.74| |[[:results:exp286|HMS-I2 1μM R06 exp286]]|1.75| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|1.85| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|1.92| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.96| |[[:results:exp453|B02 10μM R08 exp453]]|1.97| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|2.04| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|2.11| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|2.28| |[[:results:exp183|IU1-C 25μM R04 exp183]]|2.36| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|2.46| |[[:results:exp332|Adefovir 20μM R07 exp332]]|2.56| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.443| |[[:human genes:p:pole|POLE]]|0.44| |[[:human genes:p:polr2j3|POLR2J3]]|0.436| |[[:human genes:p:psmd3|PSMD3]]|0.411| |[[:human genes:g:golga6l1|GOLGA6L1]]|0.405| Global Fraction of Cell Lines Where Essential: 681/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|24/26| |bone|26/26| |breast|30/30| |central nervous system|48/49| |cervix|4/4| |colorectal|17/17| |esophagus|11/11| |fibroblast|1/1| |gastric|14/14| |kidney|16/18| |liver|18/19| |lung|70/72| |lymphocyte|16/16| |ovary|25/25| |pancreas|22/22| |peripheral nervous system|15/15| |plasma cell|12/12| |prostate|1/1| |skin|20/20| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|27/28| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 196 * **Expression level (log2 read counts)**: 9.13 {{:chemogenomics:nalm6 dist.png?nolink |}}